In the nervous system, the regulatory effect of GLP-1 RA on mitochondrial function and oxidative stress is involved in the remission of diabetes-related NDs
At Aestha Clinic, we move beyond the headlines to examine this phenomenon through the lens of evidence-based medicine and scientific rigor
References National Institutes of Health Office of Dietary Supplements MedlinePlus National Organization for Rare Disorders Mayo Clinic European Food Safety Authority This article is for general information only and is not a substitute for professional medical advice
Call 999 or go to your nearest A&E if you experience these signs
Read more: Author summary: Full meta-analysis: #BiomoleculesandBiomedicine #Biomolbiomed #journal #biomedicaljournal #openaccessjournal #peerreveiwedjournal #authorsummary #metaanalysis #SGLT2inhibitors #sulphonylureas #glycemicdurability #HbA1c #type2diabetesmellitus #diabetes #glycemiccontrol #trials #bloodsugarcontrol #medicine To view or add a comment, sign in New comparative data suggest that three GLP-1 receptor agonistsliraglutide, semaglutide, and dulaglutidedeliver similar cardiovascular and kidney benefits in people with type 2 diabetes
Diabetes, Obesity & Metabolism, 24(8), 15531564.